Mehdi Hamadani/X
Jan 15, 2025, 18:31
Mehdi Hamadani: Current status of ADCs in lymphoma DLBCL
Mehdi Hamadani, Professor of Internal Medicine at the Medical College of Wisconsin, shared on X:
“Current status of ADCs in lymphoma DLBCL.
Loved developing this invited piece with two lymphoma rising stars Gulrayz Ahmed and Taha A.”
The potential of antibody-drug conjugates for effective therapy in diffuse large B-cell lymphoma
Authors: Gulrayz Ahmed, Mehdi Hamadani and Taha Al-Juhaishi.
Mehdi Hamadani is a Professor of Internal Medicine at the Medical College of Wisconsin, where he also serves as Director of the Blood and Marrow Transplant (BMT) and Cellular Therapy Program. Additionally, he is the Associate Scientific Director at the Center for International Blood and Marrow Transplantation Research.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 10, 2025, 15:36
Aug 10, 2025, 14:54
Aug 10, 2025, 13:44
Aug 10, 2025, 12:46